Fenfluramine

This classification denotes an anorexiant with the molecular formula C12H16F3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 2DS058H2CF, chemically known as phenethylamine, n-ethyl-alpha-methyl-m-(trifluoromethyl)-, (s)- but more generally known as fenfluramine, which bears US NIH Compound Identifier 3337. European Medicines Agency schedules Fenfluramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07561MIG. The term FENFLURAMINE is an International Non-Proprietary Name. World Health Organization schedules fenfluramine in its Anatomical Therapeutic Chemical (ATC) Classification. FENFLURAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule fenfluramine under HS 29214980 and SITC 51454. As of Q4 2014, FENFLURAMINE remains US FDA's Preferred Term for this commodity. Fenfluramine bears US NLM identifiers UMLS ID C0015827 and NCI Concept Code C81418. SMILES: CCNC(C)CC1=CC(=CC=C1)C(F)(F)F.